August 2024 Br J Cardiol 2024;31(suppl 3):S19–S23 doi:10.5837/bjc.2024.s10
Paul J Andrews, Harvey Thompson
Laboratory testing of digoxin levels Laboratories in the National Health Service (NHS) acute trusts will have arrangements in place for routine therapeutic drug level monitoring of digoxin. Routine assays may not be available on a daily basis. However, local arrangements should exist to ensure the availability of urgent testing in cases of suspected digoxin toxicity 24 hours a day. One commonly used method is the electro-chemiluminescence immunoassay (Roche ECLIA®). This assay involves adding a combination of Ruthenium-labelled digoxin-specific monoclonal antibodies, a digoxin derivative labelled with biotin, and a fluorescent marker attache
August 2015 Br J Cardiol 2015;22:96–7
Heather Wetherell
This issue, we have a little teaser for GPs, who may reasonably come across this kind of electrocardiogram (ECG) any day of the week. Figure 1 shows the ECG of a well, 83-year-old woman, who attended her GP’s surgery for her ‘annual review’. As part of this review, the practice nurse carried out a routine ECG. Figure 1. The electrocardiogram obtained during the annual review Believe or not, it’s possible to answer the following three questions from this ECG: Q1: What chronic condition was being monitored at her annual review? Q2: What is she taking for this condition? Q3: What action should the GP take now? Let’s go through the ECG
July 2003 Br J Cardiol 2003;10:308-9
Handrean Soran, Louise Murray, Naveed Younis, Steve PY Wong, Peter Currie, Ian R Jones
No content available
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits